Orange Book product · Generic (ANDA)
LOVASTATIN
LOVASTATIN
At a glance
Dec 17, 2001
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Dec 17, 2001
24 yr 10 mo ago
Today
Pharmaceutical detail
Active ingredient
LOVASTATIN
Strength
10MG
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
ANDA 075828
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of LOVASTATIN
- 2002ALTOPREVBrand (NDA)
NDA 021316 · AZURITY
- 1991MEVACORBrand (NDA)
NDA 019643 · MERCK
- 2008LOVASTATINGeneric (ANDA)
ANDA 078296 · LUPIN
- 2007LOVASTATINGeneric (ANDA)
ANDA 077748 · COREPHARMA
- 2006LOVASTATINGeneric (ANDA)
ANDA 077520 · SUN PHARM INDUSTRIES
- 2002LOVASTATINGeneric (ANDA)
ANDA 075991 · CARLSBAD
- 2001LOVASTATINGeneric (ANDA)
ANDA 075451 · AUROBINDO PHARMA USA
- 2001LOVASTATINGeneric (ANDA)
ANDA 075935 · AUROBINDO PHARMA USA
- 2001LOVASTATINGeneric (ANDA)
ANDA 075300 · CHARTWELL RX
- 2001LOVASTATINGeneric (ANDA)
ANDA 075636 · EPIC PHARMA LLC
- 2001LOVASTATINGeneric (ANDA)
ANDA 075551 · TEVA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
